UH Case Medical Center first surgical site to test regen treatment for chronic stroke

April 26, 2016, University Hospitals Case Medical Center

University Hospitals Case Medical Center is the first surgical site for a Phase 2b clinical trial study to further evaluate the safety and efficacy of an investigational cell therapy for the treatment of chronic motor deficit following an ischemic stroke.

"With strokes, focus has been on prevention or treatment within the first few hours," said Jonathan Miller, MD, Director of the Center for Functional and Restorative Neurosurgery at UH Case Medical Center and Assistant Professor of Neurosurgery at Case Western Reserve University School of Medicine, who performs the stem cell surgery as part of the study. "Stroke is the leading cause of adult disability in the U.S., and there really hasn't been much for this patient population."

Ischemic strokes account for approximately 87 percent of all strokes in the US and occur when there is an obstruction in a blood vessel supplying oxygen to the brain. With approximately 800,000 strokes occurring in the United States every year, stroke is the leading cause of acquired disability in the United States. Traditional stroke treatments generally show little or no improvement in patients after the first six months following a stroke.

The ACTIsSIMA "Allogeneic Cell Therapy for Ischemic Stroke to Improve Motor Abilities" trial will examine the effects of genetically modified adult bone-marrow-derived in patients who have experienced an ischemic stroke in the previous six months to five years and still suffer from motor impairments.

Dr. Miller said, "For the hundreds of thousands of people living with the debilitating effects of ischemic stroke, the ACTIsSIMA trial will help determine whether this investigational cell therapy is a safe and effective treatment option."

The Phase 2b clinical trial follows a previous open label Phase 1/2a clinical trial in a similar patient population. The Phase 2b study will further evaluate the safety and efficacy of the treatment in a blinded and controlled setting.

The study will enroll 156 patients with chronic motor deficits after stroke. They are being recruited through 50 assessment sites throughout the United States. Patients will range in age from 18 to 75 years of age. Once enrolled through an assessment site, patients will come to one of 18 surgical sites such as UH Case Medical Center, for the injection of cells. The patient will then be monitored for the duration of the study at the assessment sites. The closest assessment sites to UH are in Toledo and Detroit.

The ACTIsSIMA trial will further evaluate the safety and efficacy of intracranial administration of modified adult bone-marrow-derived stem cells when administered to patients with chronic motor deficit secondary to ischemic stroke.

"UH Case Medical Center has been in the forefront of adult stem cell research," said Dr. Miller. "We are excited to be part of this study to evaluate the potential of this treatment for . Although it will take time, this study and others involving stem cells, may lead to new methods of helping ."

Explore further: Stroke patients show higher recovery in MultiStem therapy

Related Stories

Stroke patients show higher recovery in MultiStem therapy

February 24, 2016
Data presented by the biotech company Athersys indicate that stroke patients treated by an adult stem cell therapy called MultiStem did significantly better than others who received a placebo one year after treatment. The ...

University of Kentucky offers stroke stem cell trial

January 13, 2012
The University of Kentucky will be the first site in the state and one of a select few in the entire country participating in the first stages of a groundbreaking study to investigate the effects of MultiStem, a human adult ...

Safety results of intra-arterial stem cell clinical trial for stroke presented

October 11, 2012
Early results of a Phase II intra-arterial stem cell trial for ischemic stroke showed no adverse events associated with the first 10 patients, allowing investigators to expand the study to a targeted total of 100 patients.

Imaging, not time, may determine who is right for stroke clot removal

February 17, 2016
Brain imaging may accurately identify patients likely to benefit from stroke clot removal instead of relying on the time since symptoms began as an indicator of treatment eligibility, according to research presented at the ...

Migraine with aura linked to clot-caused strokes

February 17, 2016
People who have migraines with aura are more likely to have strokes caused by either a blood clot in the heart (cardio-embolic stroke) or a clot within the brain's blood vessels (thrombotic stroke), compared to those that ...

Northwestern Medicine researchers investigate stem cell therapy for stroke

February 11, 2013
Each year, nearly 800,000 Americans suffer a stroke which can result in permanent brain damage, long term disability or death. As a leading cause of adult disability, stroke has an annual burden of more than $62 billion on ...

Recommended for you

Noisy workplace may wreak havoc on your heart

March 22, 2018
(HealthDay)—Loud noise at work doesn't just threaten your hearing, it might also boost your blood pressure and cholesterol levels, a new U.S. government report suggests.

Smartwatch effective in detecting atrial fibrillation

March 22, 2018
Irregular heart impulses that lead to stroke can be detected with great accuracy using a smartwatch with a specially designed application, a finding that could eventually lead to new ways to screen patients for earlier treatment, ...

AI is quicker, more effective than humans in analyzing heart scans

March 22, 2018
A type of artificial intelligence known as advanced machine learning can classify essential views from heart ultrasound tests faster, more accurately and with less data than board-certified echocardiographers, according to ...

Majority of U.S. adults have poor heart health: study

March 19, 2018
(HealthDay)—America's heart health went from bad to worse between 1988 and 2014, a new report warns.

Drinking alcohol makes your heart race

March 18, 2018
The more alcohol you drink, the higher your heart rate gets, according to research presented today at EHRA 2018 Congress, organized by the European Society of Cardiology.

Study of nearly 300,000 people challenges the 'obesity paradox'

March 15, 2018
The idea that it might be possible to be overweight or obese but not at increased risk of heart disease, otherwise known as the "obesity paradox", has been challenged by a study of nearly 300,000 people published in in the ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.